A Nanotechnology-based Biosensor Targeting Salivary Biomarkers to Detect and Monitor Heart Failure
研究課題情報
- 課題管理番号
- 21jm0610044h0001
- 統合プロジェクト(二期)
シーズ開発・研究基盤プロジェクト<第二期>
- 事業名
医療分野国際科学技術共同研究開発推進事業
- タグ(2021)
研究の性格: 医療薬事制度・介護制度の改良及び技術支援等につながる研究<国際保健<制度>の技術支援等につながる研究を含む>
開発フェーズ: 応用
承認上の分類: 薬機法分類非該当
対象疾患: その他
疾患領域: 生活習慣病 , がん , 精神・神経疾患 , 老年医学・認知症 , 難病 , 成育 , 感染症
開発目的: 予防・健康 , 診断 , 生活の質<QOL>
- 代表研究機関
- 株式会社Mirai Innovation研究所
- 研究代表者
(2021) Penaloza Christian, 株式会社Mirai Innovation研究所, 認知ロボットシステム研究科 主任研究員
- 研究期間
- 2021年度 - 2021年度
- 課題への総配分額
- 3,000 千円
- 研究概要(2021)
- 当研究所の目的は、エマージングテクノロジー研究開発、コンサルティング業務、技術トレーニングの3事業を行うことにより、企業や大学等における新技術研究を支援することである。 今年度、当研究所は、国際的な大学や企業との強力な連携を構築するとともに、豊かな社会の実現を目指して科学技術の創成と発展に貢献することを目指している。これらの目的を実現するための目標は次の通りである。 1)エマージングテクノロジーの各分野において国際的に高い水準の研究を行う。 2)若手研究者が活気づく国際的な研究環境整備を図る。 3)国際的な大学や企業との強力な連携を整備する。
研究成果情報
2021
成果の概要
keyboard_arrow_down
Significance:
Congestive heart failure (CHF) is a common disease affecting the aging population and is the leading cause of mortality worldwide. Early detection and treatment of CHF remains a significant health challenge, necessitating the development of approaches for reliable non-invasive diagnostic and monitoring solutions. Saliva is known to contain many clinical biomarkers specific to cardiovascular diseases including CHF. Therefore, it is critical to come up with sustainable technology to monitor saliva biomarkers associated with CHF at home.
Objective:
The overall objective of this research is to develop a novel nanofibrous (NF)-based electrochemical biosensor framework integrated into a mouth guard capable of detecting CHF-specific biomarkers with high sensitivity and specificity from saliva as shown in Figure 1.
Figure 1 Schematic illustration of our technology proposal for remote monitoring of CHF biomarkers from saliva a) wearable electrospun biosensors b) conformably integration into a mouthguard c & d) docking station to analysis the saliva and mobile app for remote
Specific Aims:
Aim 1: Design and develop a NF-based biofiber capable of detecting concentration changes of specific clinical biomarkers for CHF
Aim 2: Conduct a feasibility analysis of the sensitivity and quantitative accuracy of the NF-based biofiber.
Aim 3: Develop an electronic device to monitor the health of wearer’s saliva to be coated with the NF-based biosensor.
Result of Aim 1: Preparation and characterization of the Electrospun nanofibers
Here, a flexible and breathable sensing biofiber was fabricated to sensitively detect congestive heart failure biomarkers (cardiotroponin-I and pro-brain natriuretic peptide) in saliva. The mechanically flexible polycaprolactone (PCL) was successfully obtained (Fig 2) and was coated with graphene oxide for electrically conductive. Fig 3A shows the SEM images of the electrospun nanofibrous membrane with high porosity and surface area allowing for effective and adequate contact between target reactants and working electrode.
Figure 2: Fabrication of nanofibers A) Conventional electrospinning set-up to collecting nanofibers onto a rotating metal grounded collector B) Macroscope image of nanofibrous mat collected on aluminum foil.
Figure 3: A) Scanning electron microscope image of the nanofiber membrane fromed from polycaprolactone polymer. B) Setup of three-electrode measurement of patch-type nanofibrous membrane using commercially available biosensor.
Result of Aim 2: Feasibility analysis of electrospun fibers electrode to detect congestive heart failure biomarker
Brain natriuretic peptide (BNP) and cardiotroponin-1 (cTn) are widely used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical medicine. Therefore feasibility of BNP and cTn by the of uric this developed nanofibrous was systematically analyzed using commercially available screen-printed carbon electrode (SPCE). Thus, the electrochemical signal changes of different were recorded by cyclic voltammetry (CV) in PBS solution and 250 ug of BNP and 10ug of cTn. The electrochemistry of nanofibrous hydrated with biomarker and PBS (pH 7.4) was studied by cyclic voltammetry. Fig 4A shows the overlaid CVs difference considering cyclic area of the curve possibly due to charging of BNP molecules. However, prominent oxidation and reduction peaks are not seen in CV. Fig 4B shows the overlaid DPVs prominent reduction current of BNP molecules suggesting precise BNP reduction and its corresponding current/ specific reduction potential would an electrochemical signature for its detection using electrochemical techniques. For cardiotrophonin a pair of well-defined and quasi-reversible redox peaks were observed at the CVs of nanofibres. Overall, our findings suggest that electrospun fiber is feasible to use as working electrode and that it might be applied to different physiological fluids (such as subcutaneous tissue fluid, ISF, and saliva).
Figure 4: A) Cyclic Voltammograms of Screen-Printed Carbon Electrode (SPCE) modified with Bismuth (III) Oxide (Bi2O3) in PBS and BNP solution in PBS. Scan rate 100mV/s. B) Differential Pulse Voltammograms of Screen-Printed Carbon Electrode (SPCE) modified with Bismuth (III) Oxide (Bi2O3) in PBS and BNP solution in PBS.
Figure 4: Cyclic Voltammograms of Screen-Printed Carbon Electrode (SPCE) modified with Bismuth (III) Oxide (Bi2O3) comparing PBS, BNP and cTn-1 signals. Scan rate 100mV/s
Result of Aim 3: Develop an electronic device to monitor the health of wearer’s saliva to be coated with the NF-based biosensor.
A mouth guard docking station consisting of an electronic board, a microcontroller and a software interface was developed. The electronic board (Fig. 5a) is able to measure the electrical conductivity based on reference previously calibrated with a neutral solution such as water. The microcontroller acquires the conductivity data from the electronic board via I2C communication which is then sent to a computer via a software interface as shown in Fig. 5b.
The preliminary test was conducted using measurements of different concentrations of phosphate buffer saline (PBS) solution. The graph in Fig. 6, shows the normalized conductance corresponding to the different amounts of concentrations of PBS that was measured by our system. The test results shows the correctly ascending linear correlation of conductance with an increasing amount of PBS.
Congestive heart failure (CHF) is a common disease affecting the aging population and is the leading cause of mortality worldwide. Early detection and treatment of CHF remains a significant health challenge, necessitating the development of approaches for reliable non-invasive diagnostic and monitoring solutions. Saliva is known to contain many clinical biomarkers specific to cardiovascular diseases including CHF. Therefore, it is critical to come up with sustainable technology to monitor saliva biomarkers associated with CHF at home.
Objective:
The overall objective of this research is to develop a novel nanofibrous (NF)-based electrochemical biosensor framework integrated into a mouth guard capable of detecting CHF-specific biomarkers with high sensitivity and specificity from saliva as shown in Figure 1.
Figure 1 Schematic illustration of our technology proposal for remote monitoring of CHF biomarkers from saliva a) wearable electrospun biosensors b) conformably integration into a mouthguard c & d) docking station to analysis the saliva and mobile app for remote
Specific Aims:
Aim 1: Design and develop a NF-based biofiber capable of detecting concentration changes of specific clinical biomarkers for CHF
Aim 2: Conduct a feasibility analysis of the sensitivity and quantitative accuracy of the NF-based biofiber.
Aim 3: Develop an electronic device to monitor the health of wearer’s saliva to be coated with the NF-based biosensor.
Result of Aim 1: Preparation and characterization of the Electrospun nanofibers
Here, a flexible and breathable sensing biofiber was fabricated to sensitively detect congestive heart failure biomarkers (cardiotroponin-I and pro-brain natriuretic peptide) in saliva. The mechanically flexible polycaprolactone (PCL) was successfully obtained (Fig 2) and was coated with graphene oxide for electrically conductive. Fig 3A shows the SEM images of the electrospun nanofibrous membrane with high porosity and surface area allowing for effective and adequate contact between target reactants and working electrode.
Figure 2: Fabrication of nanofibers A) Conventional electrospinning set-up to collecting nanofibers onto a rotating metal grounded collector B) Macroscope image of nanofibrous mat collected on aluminum foil.
Figure 3: A) Scanning electron microscope image of the nanofiber membrane fromed from polycaprolactone polymer. B) Setup of three-electrode measurement of patch-type nanofibrous membrane using commercially available biosensor.
Result of Aim 2: Feasibility analysis of electrospun fibers electrode to detect congestive heart failure biomarker
Brain natriuretic peptide (BNP) and cardiotroponin-1 (cTn) are widely used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical medicine. Therefore feasibility of BNP and cTn by the of uric this developed nanofibrous was systematically analyzed using commercially available screen-printed carbon electrode (SPCE). Thus, the electrochemical signal changes of different were recorded by cyclic voltammetry (CV) in PBS solution and 250 ug of BNP and 10ug of cTn. The electrochemistry of nanofibrous hydrated with biomarker and PBS (pH 7.4) was studied by cyclic voltammetry. Fig 4A shows the overlaid CVs difference considering cyclic area of the curve possibly due to charging of BNP molecules. However, prominent oxidation and reduction peaks are not seen in CV. Fig 4B shows the overlaid DPVs prominent reduction current of BNP molecules suggesting precise BNP reduction and its corresponding current/ specific reduction potential would an electrochemical signature for its detection using electrochemical techniques. For cardiotrophonin a pair of well-defined and quasi-reversible redox peaks were observed at the CVs of nanofibres. Overall, our findings suggest that electrospun fiber is feasible to use as working electrode and that it might be applied to different physiological fluids (such as subcutaneous tissue fluid, ISF, and saliva).
Figure 4: A) Cyclic Voltammograms of Screen-Printed Carbon Electrode (SPCE) modified with Bismuth (III) Oxide (Bi2O3) in PBS and BNP solution in PBS. Scan rate 100mV/s. B) Differential Pulse Voltammograms of Screen-Printed Carbon Electrode (SPCE) modified with Bismuth (III) Oxide (Bi2O3) in PBS and BNP solution in PBS.
Figure 4: Cyclic Voltammograms of Screen-Printed Carbon Electrode (SPCE) modified with Bismuth (III) Oxide (Bi2O3) comparing PBS, BNP and cTn-1 signals. Scan rate 100mV/s
Result of Aim 3: Develop an electronic device to monitor the health of wearer’s saliva to be coated with the NF-based biosensor.
A mouth guard docking station consisting of an electronic board, a microcontroller and a software interface was developed. The electronic board (Fig. 5a) is able to measure the electrical conductivity based on reference previously calibrated with a neutral solution such as water. The microcontroller acquires the conductivity data from the electronic board via I2C communication which is then sent to a computer via a software interface as shown in Fig. 5b.
The preliminary test was conducted using measurements of different concentrations of phosphate buffer saline (PBS) solution. The graph in Fig. 6, shows the normalized conductance corresponding to the different amounts of concentrations of PBS that was measured by our system. The test results shows the correctly ascending linear correlation of conductance with an increasing amount of PBS.
学会誌・雑誌等における論文一覧
keyboard_arrow_down
1. Penaloza C., Nilesh, D., Honwu W., A nanotechnology-based biosensor targeting salivary biomarkers to detect and monitor heart failure. Journal of Biosensors and Bioelectronics. 2022 (Under review)